Hong Kong Electric Utilities Stock News

Quam Plus International Financial (SEHK:952) has posted its FY 2025 first half results, with revenue of HK$165.2 million and basic EPS of HK$0.00041, setting a measured tone around profitability at a current share price of HK$0.14. The company has seen revenue move from HK$152.9 million in the first half of FY 2024 to HK$165.2 million in the first half of FY 2025. Over the same periods, basic EPS shifted from HK$0.001816 to HK$0.00041, putting the focus squarely on how efficiently that top...

Beijing Enterprises Urban Resources Group (SEHK:3718) has reported FY 2025 first half revenue of CN¥3.0b and basic EPS of CN¥0.009143, with the trailing 12 month figures showing CN¥6.3b of revenue and EPS of CN¥0.0622 that tie into a very large year on year earnings jump and an improvement in net profit margin to 3.5% from 0.4%. The company has seen revenue move from CN¥2.7b in the first half of FY 2024 to CN¥3.0b in the first half of FY 2025, alongside basic EPS that shifted from CN¥0.036098...

Auntea Jenny (Shanghai) Industrial (SEHK:2589) has reported first half FY 2025 results with revenue of C¥1.8b, basic EPS of C¥1.97 and net income excluding extra items of C¥202.9m. The company has seen first half revenue move from C¥1.66b in FY 2024 to C¥1.8b in FY 2025, with basic EPS shifting from C¥1.65 to C¥1.97 and net income excluding extra items from C¥167.8m to C¥202.9m. Trailing twelve month figures show revenue of C¥4.5b, net income of C¥501.3m and basic EPS of C¥4.81, putting...

K Cash (SEHK:2483) has put fresh numbers on the table for FY 2025, with first half revenue of HK$101.4 million and basic EPS of HK$0.088, setting the tone for how you might judge its recent progress. Over the past few reporting periods the company has seen revenue move from HK$84.7 million in 1H 2024 to HK$87.2 million in 2H 2024 and then to HK$101.4 million in 1H 2025, while basic EPS has shifted from HK$0.068 to HK$0.059 and then to HK$0.088 across the same timeline. This gives you a clear...

Yihai International Holding (SEHK:1579) opened FY 2025 with first half revenue of C¥2.9b and basic EPS of C¥0.32, backed by trailing twelve month revenue of C¥6.6b and EPS of C¥0.88 that frame the current run rate. The company has seen revenue move from C¥2.9b and EPS of C¥0.32 in 1H 2024 to C¥3.6b and EPS of C¥0.44 in 2H 2024, alongside trailing twelve month net income of C¥854m that reflects the earnings power behind its recent margin profile. With net profit margins sitting in the low...

Green Tea Group (SEHK:6831) has reported its FY 2025 first half results with revenue of C¥2.3b and basic EPS of C¥0.42, setting the tone for a year where trailing twelve month EPS reached C¥0.80 on revenue of C¥4.8b. Over recent periods the company has seen revenue move from C¥3.6b and EPS of C¥0.55 in the second half of 2023 to C¥3.8b and EPS of C¥0.66 in the second half of 2024, alongside first half 2025 revenue of C¥2.3b and EPS of C¥0.42. This points to a business where scale and per...

Nongfu Spring (SEHK:9633) has reported another solid set of numbers, with FY 2025 first half revenue at about C¥25.6b and basic EPS of C¥0.68, backed by trailing twelve month EPS of C¥1.41 on revenue of roughly C¥52.6b. The company has seen revenue progress from C¥42.9b to C¥52.6b over the last twelve months, while trailing EPS has moved from C¥1.08 to C¥1.41, providing a clear view of how profitability is tracking. For investors, the key takeaway is that margins are doing more of the heavy...

Sisram Medical (SEHK:1696) has released its FY 2025 first half results, reporting revenue of US$165.5 million and basic EPS of US$0.0137, setting the stage against a backdrop of trailing twelve month revenue of US$365.3 million and EPS of US$0.0406. The company has seen revenue move from US$168.7 million and EPS of US$0.0234 in the first half of 2024 to US$180.4 million and EPS of US$0.0303 in the second half of 2024, giving you a clear view of how the latest numbers sit within its recent...

SEM Holdings (SEHK:9929) has laid out a mixed set of FY 2025 numbers, with first half revenue of HK$21.5 million and basic EPS of HK$0.00011, while the trailing twelve months to the second half of FY 2025 show revenue of HK$66.3 million and a loss per share of HK$0.0094. Over recent reporting periods, the company has seen revenue shift from HK$50.9 million in the first half of FY 2024 to HK$40.8 million in the second half of FY 2024 and then to HK$21.5 million in the first half of FY 2025...

WH Group (SEHK:288) has set out its FY 2025 scorecard with second half revenue of about US$14.6b and basic EPS of US$0.0607, while trailing twelve month revenue sits at roughly US$28.0b with EPS of US$0.1221. Over recent periods the company has seen revenue move from about US$13.6b in 2H 2024 to US$13.4b in 1H 2025 and then to US$14.6b in 2H 2025, with basic EPS shifting from US$0.0645 in 2H 2024 to US$0.0614 in 1H 2025 and US$0.0607 in 2H 2025. This sets the backdrop for investors weighing...

CIMC Enric Holdings (SEHK:3899) has laid out its latest scorecard with FY 2025 first half revenue of about C¥12.6b and basic EPS of C¥0.28, giving investors fresh data to weigh against the current share price of HK$11.10. Over the past few periods, the company has seen revenue move from C¥11.5b and EPS of C¥0.24 in 1H 2024 to C¥13.3b and EPS of C¥0.30 in 2H 2024. Trailing twelve month revenue most recently sat at roughly C¥26.3b with EPS of C¥0.56, putting the spotlight on how consistently it...

Guangzhou Innogen Pharmaceutical Group (SEHK:2591) has reported its FY 2025 first half with revenue of C¥56.4 million, a basic EPS loss of C¥0.29 and net income loss of C¥122.47 million, while trailing twelve month figures show revenue of C¥131.5 million, a basic EPS loss of C¥0.79 and net income loss of C¥341.36 million. The company has seen first half revenue move from C¥0 in FY 2024 to C¥56.4 million in FY 2025 as EPS moved from a basic loss of C¥0.18 to a loss of C¥0.29. This sets up a...

Giordano International (SEHK:709) has put up a steady set of FY 2025 numbers, with first half revenue at HK$1,934 million and basic EPS of HK$0.075, supported by trailing twelve month revenue of HK$3,854 million and EPS of HK$0.134 that frame the latest run rate. The company has seen revenue move from HK$1,903 million in the first half of FY 2024 to HK$2,016 million in the second half and then to HK$1,934 million in the first half of FY 2025, while basic EPS tracked HK$0.074 in early FY...

Tradelink Electronic Commerce (SEHK:536) has opened FY 2025 with first half revenue of HK$121.0 million and basic EPS of HK$0.0526, alongside trailing twelve month revenue of HK$252.7 million and EPS of HK$0.106 that frame the latest figures in a broader context. Over recent periods, revenue has moved between HK$122.7 million and HK$125.0 million per half while basic EPS has ranged from HK$0.0512 to HK$0.0526, setting a relatively tight band for top line and per share performance as you look...

China Railway Signal & Communication (SEHK:3969) has reported its FY 2025 results with fourth quarter revenue of about C¥12.9b and basic EPS of C¥0.11. This is set against a trailing twelve month EPS of C¥0.34 that reflects 5.5% earnings growth over the past year and a net profit margin of 10.6%. Over recent periods, revenue has moved from roughly C¥11.7b in Q4 2024 to C¥12.9b in Q4 2025, while quarterly EPS shifted from C¥0.10 to C¥0.11 on this comparison. With earnings growth outpacing the...

Health and Happiness (H&H) International Holdings (SEHK:1112) has reported FY 2025 first half revenue of C¥7.0b and basic EPS of C¥0.11, with the trailing twelve months showing revenue of C¥14.4b and basic EPS of C¥0.31 as profitability returned over the year. The company has seen revenue move from C¥6.7b in 1H 2024 to C¥7.0b in 1H 2025, while basic EPS shifted from C¥0.48 in 1H 2024 to C¥0.11 in 1H 2025. This sets up a results season in which investors will be weighing the earnings rebound...

Best Pacific International Holdings (SEHK:2111) has posted its FY 2025 first half results with revenue of HK$2,329.8 million and basic EPS of HK$0.25, setting the tone against a backdrop of forecast earnings growth of about 18.6% per year and revenue growth of roughly 8.8% per year. The company has seen revenue move from HK$2,385.4 million in 1H 2024 to HK$2,675.9 million in 2H 2024 and then to HK$2,329.8 million in 1H 2025, while EPS has shifted from HK$0.27 to HK$0.32 and now HK$0.25. This...

Haidilao International Holding (SEHK:6862) has wrapped up FY 2025 with second half revenue of C¥22.5b and basic EPS of C¥0.42, while trailing twelve month revenue sits at C¥43.2b and EPS at C¥0.75. This frames a set of results that investors can benchmark against both recent and multi year growth. The company has seen half year revenue move from C¥21.3b in 2H 2024 to C¥22.5b in 2H 2025, with basic EPS shifting from C¥0.49 to C¥0.42 over the same period. This sets up a debate about how profit...

WuXi Biologics (Cayman) (SEHK:2269) has reported its FY 2025 numbers with second half revenue of about C¥11.8b and basic EPS of C¥0.64, supported by trailing twelve month revenue of roughly C¥21.8b and EPS of C¥1.22 that sit alongside a 46.3% year over year earnings gain. The company has seen revenue move from around C¥18.7b to C¥21.8b on a trailing basis, while trailing EPS has shifted from C¥0.82 to C¥1.22, setting up a story where rising profit levels are paired with healthier margins that...

Duality Biotherapeutics (SEHK:9606) has just posted its FY 2025 first half results, with revenue of C¥1.2b and a basic EPS loss of C¥49.73, set against a net income loss of C¥2.1b. Over the same half year a year earlier, the company reported revenue of C¥1.0b and a basic EPS loss of C¥36.68, while trailing twelve month figures show revenue of C¥1.9b and a basic EPS loss of C¥39.80 as losses widened to C¥2.6b. For investors, the key theme this period is the tension between increasing revenue...

MIXUE Group (SEHK:2097) FY 2025 earnings snapshot MIXUE Group (SEHK:2097) has reported FY 2025 results with second half revenue of C¥18.7b and basic EPS of C¥2.82, alongside trailing 12 month revenue of C¥33.6b and EPS of C¥7.83, giving investors a fresh look at how the business is scaling. The company has seen revenue move from C¥10.7b and EPS of C¥5.23 in the first half of 2024 to C¥14.9b and EPS of C¥7.23 in the first half of 2025, with trailing 12 month revenue stepping up from C¥24.8b...

Ping An Healthcare and Technology (SEHK:1833) has just posted its FY 2025 first half numbers, with revenue at C¥2.5b and basic EPS of C¥0.07, alongside net income of C¥134.2m that builds on its recent move into profitability. Over the recent reporting periods, revenue has shifted from C¥2.1b in 1H 2024 to C¥2.7b in 2H 2024 and C¥2.5b in 1H 2025, while basic EPS has moved from C¥0.05 in 1H 2024 to C¥0.02 in 2H 2024 and C¥0.07 in 1H 2025. This sets up a results story where investors will be...

Orient Overseas (International) (SEHK:316) shares were in focus after the company reported full year 2025 results showing lower sales and net income, alongside a proposed final dividend of US$0.42 per share payable in multiple currencies. See our latest analysis for Orient Overseas (International). The latest earnings update, which includes lower sales and net income alongside a proposed US$0.42 dividend, comes as the share price sits at HK$144.2 with a 90 day share price return of 16.1%. The...

What the latest results and board changes mean for Samsonite Group Samsonite Group (SEHK:1910) just packed several developments into one update, combining full year 2025 earnings, a proposed US$140 million dividend, a planned chairmanship handover and shareholder approval to prepare for a potential US dual listing. See our latest analysis for Samsonite Group. Those announcements landed after a tough stretch for the stock, with a 30 day share price return of 23.03% decline and a year to date...